Kexing Biopharm Secures IND Approval for Innovative GB05 in the U.S. Kexing Biopharm's GB05, an inhalation treatment for RSV, receives IND approval from the FDA, paving the way for clinical trials in the U.S.

Kexing Biopharm Secures IND Approval for Innovative GB05 in the U.S. #China #Shenzhen #Kexing_Biopharm #GB05 #RSV_Treatment